eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
abstract:
Original paper

Triptolide promotes nerve repair after cerebral ischemia reperfusion injury by regulating the NogoA/NgR/ROCK pathway

Huiyu Zhang
1
,
Minfang Guo
2
,
Peijun Zhang
2
,
Bingtao Mu
2
,
Zhenjun Bai
1
,
Liang Li
1
,
Jingwen Yu
2

  1. College of Traditional Chinese Medicine Health Service, Shanxi Datong University, Datong, China
  2. Institute of Brain Science, Shanxi Datong University, Datong, China
Folia Neuropathol 2023; 61:
Online publish date: 2023/11/23
View full text Get citation
 
PlumX metrics:
Activation of the NogoA/NgR/ROCK pathway limits nerve repair after brain ischemia-reperfusion (I/R) injury. Triptolide displays anti-inflammatory, anti-oxidant, and immunosuppressive effects and is derived from the traditional Chinese medicine Tripterygium wilfordii Hook F. This agent can also penetrate the blood-brain barrier, where it has a neuroprotective effect and ameliorates cerebral I/R injury via an as yet unknown mechanism(s). Here, an animal model of middle cerebral artery occlusion and reperfusion (MCAO/R) was employed to assess triptolide’s therapeutic impact on brain I/R injury and the possible mechanism of action. The results indicate that triptolide treatment can decrease cerebral infarction and nerve injury after cerebral I/R injury. Importantly, in vivo and in vitro experiments revealed that treatment with triptolide decreased NogoA, NgR, p75NTR and ROCK2 expression, and upregulated the expression of GAP43 and PSD-95, thus suggesting improved synaptic function. These results indicate that triptolide can promote nerve repair following brain I/R injury by inhibiting NogoA/NgR/ROCK signalling.
keywords:

triptolide, cerebral ischemia/reperfusion, NogoA/NgR/ROCK signalling pathway, neuroregeneration

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.